Skip to content
Medical Health Aged Care

A mother’s diet can protect her grandchildren’s brains: genetic model study

Monash University 2 mins read

Mothers who eat apples and herbs in early pregnancy could be protecting the brain health of their children and grandchildren, a Monash University study using genetic models has found.

 

The discovery is part of a project that found a mother’s diet can affect not just her child’s brain but also those of her grandchildren.

 

Published in Nature Cell Biology, the Monash Biomedicine Discovery Institute study found that certain foods could help protect against the deterioration of brain function.

 

More specifically, the study used roundworms (Caenorhabditis elegans) as the genetic model because many of their genes are also found conserved in humans, allowing insights into human cells.

 

The researchers found that a molecule present in apples and herbs (basil, rosemary, thyme, oregano, and sage) helped reduce the breakdown of communication cables needed for the brain to work properly.

 

Senior author Professor Roger Pocock and his team were investigating nerve cells in the brain that connect and communicate with each other through about 850,000 kilometres of cables called axons. For axons to function and survive, essential materials need to be transported along an internal structure that contains microtubules.

 

Professor Pocock explained that a malfunction that caused the axons to become fragile led to brain dysfunction and neurodegeneration. 

 

He said his team used a genetic model with fragile axons that break as animals age. “We asked whether natural products found in the diet can stabilise these axons and prevent breakage,” he explained.

 

“We identified a molecule found in apples and herbs (ursolic acid) that reduces axon fragility. How? We found that ursolic acid causes a gene to turn on that makes a specific type of fat. This particular fat also prevented axon fragility as animals age by improving axon transport and therefore its overall health.”

 

Professor Pocock said this type of fat, known as a sphingolipid, had to travel from the mother’s intestine, where food is digested, to eggs in the uterus for it to protect axons in the next generation. He said while the results were promising, they still need to be confirmed in humans.

 

“This is the first time that a lipid/fat has been shown to be inherited,” he said. “Further, feeding the mother the sphingolipid protects the axons of two subsequent generations. This means a mother’s diet can affect not just their offspring’s brain but potentially subsequent generations.  Our work supports a healthy diet during pregnancy for optimal brain development and health.”


Read the full paper published in Nature Cell Biology, titled An Intestinal Sphingolipid Confers Intergenerational Neuroprotection

DOI: 10.1038/s41556-023-01195-9


For media enquiries please contact:

Monash University

Cheryl Critchley - Communications Manager (medical)
E:
[email protected]

T: +61 (0) 418 312 596

 

For more Monash media stories, visit our news and events site 


For general media enquiries please contact:
Monash Media
E: 
[email protected]
T: +61 (0) 3 9903 4840

About the Monash Biomedicine Discovery Institute

Committed to making the discoveries that will relieve the future burden of disease, the Monash Biomedicine Discovery Institute (BDI) at Monash University brings together more than 120 internationally-renowned research teams. Spanning seven discovery programs across Cancer, Cardiovascular Disease, Development and Stem Cells, Infection, Immunity, Metabolism, Diabetes and Obesity, and Neuroscience, Monash BDI is one of the largest biomedical research institutes in Australia. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.

 

 

***ENDS***

More from this category

  • Medical Health Aged Care
  • 18/11/2025
  • 18:11
Debiopharm

Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New “Ideal Japan” Program

After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research…

  • Contains:
  • Medical Health Aged Care
  • 18/11/2025
  • 18:11
Amoeba

A natural breakthrough in protecting cereals and field crops

Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UKChassieu, France Basel, Switzerland , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Amoebas. These single-celled microorganisms are now at the heart of one of agriculture’s latest biological innovation – a bio-fungicide capable of protecting wheat and other cereal crops from crippling fungal diseases that cost global agriculture billions of dollars in annual crop losses and quality.This new development, made from the lysate of the amoeba Willaertia magna C2c Maky, holds strong potential to advance biological crop protection. In trials, the candidate demonstrated its effectiveness in combating the fungi…

  • Government TAS, Medical Health Aged Care
  • 18/11/2025
  • 14:28
TAS CAHRD and Hepatitis Australia

‘Ever had a tattoo back in the day?’ – New campaign urges Tasmanians to ‘get tested and get cured’ of hepatitis C

MEDIA RELEASE Embargoed until 11:59PM – Tuesday 18 November ‘Ever had a tattoo back in the day?’ New campaign urges Australians to ‘get tested and get cured’ for hepatitis C Media release: Wednesday, 19 November 2025 Ever had a tattoo back in the day? Or had a medical or cosmetic procedure, or body piercing overseas? Ever injected steroids or drugs? Even just once? You could have hepatitis C and not even know it… With men twice as likely to be affected by hepatitis C compared with women, that’s the key messageHepatitis Australia, in partnership withTasCAHRD, is putting front and centre…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.